NMTC Annual Revenue
$3.45 M
+$1.50 M+76.86%
30 September 2024
Summary:
As of January 23, 2025, NMTC annual revenue is $3.45 million, with the most recent change of +$1.50 million (+76.86%) on September 30, 2024. During the last 3 years, it has risen by +$3.27 million (+1838.80%). NMTC annual revenue is now at all-time high.NMTC Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NMTC Quarterly Revenue
$272.30 K
-$553.50 K-67.03%
30 September 2024
Summary:
As of January 23, 2025, NMTC quarterly revenue is $272.30 thousand, with the most recent change of -$553.50 thousand (-67.03%) on September 30, 2024. Over the past year, it has dropped by -$469.50 thousand (-63.29%). NMTC quarterly revenue is now -80.23% below its all-time high of $1.38 million, reached on March 31, 2024.NMTC Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NMTC TTM Revenue
$3.45 M
-$469.50 K-11.97%
30 September 2024
Summary:
As of January 23, 2025, NMTC TTM revenue is $3.45 million, with the most recent change of -$469.50 thousand (-11.97%) on September 30, 2024. Over the past year, it has increased by +$1.50 million (+76.85%). NMTC TTM revenue is now -11.97% below its all-time high of $3.92 million, reached on June 30, 2024.NMTC TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NMTC Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +76.9% | -63.3% | +76.8% |
| 3 y3 years | +1838.8% | +708.0% | +2361.2% |
| 5 y5 years | - | - | - |
NMTC Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1916.9% | -80.2% | +750.9% | -12.0% | +2361.2% |
| 5 y | 5-year | at high | +1916.9% | -80.2% | +1396.2% | -12.0% | +4729.4% |
| alltime | all time | at high | >+9999.0% | -80.2% | -12.0% | >+9999.0% |
NeuroOne Medical Technologies Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | $3.45 M(+76.9%) | $272.30 K(-67.0%) | $3.45 M(-12.0%) |
| June 2024 | - | $825.80 K(-40.0%) | $3.92 M(+5.3%) |
| Mar 2024 | - | $1.38 M(+40.9%) | $3.73 M(+32.4%) |
| Dec 2023 | - | $977.60 K(+31.8%) | $2.82 M(+44.2%) |
| Sept 2023 | $1.95 M(+1040.4%) | $741.80 K(+17.8%) | $1.95 M(+52.6%) |
| June 2023 | - | $629.90 K(+35.1%) | $1.28 M(+87.7%) |
| Mar 2023 | - | $466.20 K(+306.8%) | $681.60 K(+170.5%) |
| Dec 2022 | - | $114.60 K(+66.6%) | $252.00 K(+47.3%) |
| Sept 2022 | $171.20 K(-3.9%) | $68.80 K(+115.0%) | $171.10 K(+13.6%) |
| June 2022 | - | $32.00 K(-12.6%) | $150.60 K(-5.1%) |
| Mar 2022 | - | $36.60 K(+8.6%) | $158.70 K(+13.1%) |
| Dec 2021 | - | $33.70 K(-30.2%) | $140.30 K(-21.2%) |
| Sept 2021 | $178.10 K(>+9900.0%) | $48.30 K(+20.4%) | $178.10 K(+37.2%) |
| June 2021 | - | $40.10 K(+120.3%) | $129.80 K(+44.7%) |
| Mar 2021 | - | $18.20 K(-74.5%) | $89.70 K(+25.5%) |
| Dec 2020 | - | $71.50 K(>+9900.0%) | $71.50 K(>+9900.0%) |
| Mar 2015 | - | $100.00(-50.0%) | $700.00(-12.5%) |
| Dec 2014 | $800.00 | $200.00(+100.0%) | $800.00(+14.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2014 | - | $100.00(-66.7%) | $700.00(-22.2%) |
| June 2014 | - | $300.00(+50.0%) | $900.00(-18.2%) |
| Mar 2014 | - | $200.00(+100.0%) | $1100.00(-15.4%) |
| Dec 2013 | $1200.00(+33.3%) | $100.00(-66.7%) | $1300.00(-18.8%) |
| Sept 2013 | - | $300.00(-40.0%) | $1600.00(+23.1%) |
| June 2013 | - | $500.00(+25.0%) | $1300.00(+8.3%) |
| Mar 2013 | - | $400.00(0.0%) | $1200.00(+33.3%) |
| Dec 2012 | $900.00(-83.3%) | $400.00(>+9900.0%) | $900.00(+12.5%) |
| Sept 2012 | - | $0.00(-100.0%) | $800.00(-50.0%) |
| June 2012 | - | $400.00(+300.0%) | $1600.00(-33.3%) |
| Mar 2012 | - | $100.00(-66.7%) | $2400.00(-55.6%) |
| Dec 2011 | $5400.00(+350.0%) | $300.00(-62.5%) | $5400.00(+5.9%) |
| Sept 2011 | - | $800.00(-33.3%) | $5100.00(+10.9%) |
| June 2011 | - | $1200.00(-61.3%) | $4600.00(+21.1%) |
| Mar 2011 | - | $3100.00(+933.3%) | $3800.00(+442.9%) |
| Dec 2010 | $1200.00 | - | - |
| Sept 2010 | - | $300.00(-25.0%) | $700.00(+75.0%) |
| June 2010 | - | $400.00 | $400.00 |
FAQ
- What is NeuroOne Medical Technologies annual revenue?
- What is the all time high annual revenue for NeuroOne Medical Technologies?
- What is NeuroOne Medical Technologies annual revenue year-on-year change?
- What is NeuroOne Medical Technologies quarterly revenue?
- What is the all time high quarterly revenue for NeuroOne Medical Technologies?
- What is NeuroOne Medical Technologies quarterly revenue year-on-year change?
- What is NeuroOne Medical Technologies TTM revenue?
- What is the all time high TTM revenue for NeuroOne Medical Technologies?
- What is NeuroOne Medical Technologies TTM revenue year-on-year change?
What is NeuroOne Medical Technologies annual revenue?
The current annual revenue of NMTC is $3.45 M
What is the all time high annual revenue for NeuroOne Medical Technologies?
NeuroOne Medical Technologies all-time high annual revenue is $3.45 M
What is NeuroOne Medical Technologies annual revenue year-on-year change?
Over the past year, NMTC annual revenue has changed by +$1.50 M (+76.86%)
What is NeuroOne Medical Technologies quarterly revenue?
The current quarterly revenue of NMTC is $272.30 K
What is the all time high quarterly revenue for NeuroOne Medical Technologies?
NeuroOne Medical Technologies all-time high quarterly revenue is $1.38 M
What is NeuroOne Medical Technologies quarterly revenue year-on-year change?
Over the past year, NMTC quarterly revenue has changed by -$469.50 K (-63.29%)
What is NeuroOne Medical Technologies TTM revenue?
The current TTM revenue of NMTC is $3.45 M
What is the all time high TTM revenue for NeuroOne Medical Technologies?
NeuroOne Medical Technologies all-time high TTM revenue is $3.92 M
What is NeuroOne Medical Technologies TTM revenue year-on-year change?
Over the past year, NMTC TTM revenue has changed by +$1.50 M (+76.85%)